OECD’s Working Party on Manufactured Nanomaterials (WPMN) launched a Sponsorship Programme in November 2007. The programme involves OECD member countries, as well as some non-member economies and other stakeholders to pool expertise and to fund the safety testing of specific Manufactured Nanomaterials (MNs). In launching this Sponsorship Programme, the WPMN agreed on a priority list of 13 MNs for testing (based on materials which are
This workshop will examine ways in which knowledge contributes to innovation, especially in developing countries.
This paper discusses actors and resources in China's science and innovation system, science & technology performance and general purpose technologies. It provided input to the OECD Review of China's Innovation Policy. An annex assesses international comparability of China's S&T indicators.
English, , 872kb
The Nanoscale Materials Stewardship Program (NMSP) was developed to help provide a firmer scientific foundation for regulatory decisions by encouraging submission and development of information for nanoscale materials. The NMSP comprised two sub-programs, the Basic Program and the In-Depth Program. When the NMSP was initiated, EPA committed to issue this interim report after one year. The Agency welcomes comments on this interim
English, , 1,189kb
This report is based on an examination of some 20 roadmaps. It focuses on the process through which they were prepared, and identifies key considerations and good practices that deserve the attention of anyone contemplating the undertaking of a new roadmapping exercise.
This paper presents different indicators using existing data on R&D investments, innovation survey data, patent data and data on licensing, illustrating the increasing importance and the different characteristics of open innovation across companies, industries and countries.
English, , 80kb
Two-page brief presenting the OECD Innovation Strategy. Complete information on the project is available at www.oecd.org/innovation/strategy.
This working paper reflects an initial analysis using a pioneering new OECD database. It is among the first systematic attempts to analyse comparatively the distribution of innovative activity across OECD regions with a set of homogenous measures.
The impact of biotechnologies on medical research is intensifying. Because of new highly performing technologies, we are better able to understand and explore disease and drug mechanisms, which in turn could lead to major changes in the approach of patient care.
The STI Outlook uses the latest available data and indicators to review key trends in science, technology and innovation in OECD countries and a number of major non-member economies.